You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Steroid refractory chronic graft vs host disease (cGVHD)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Ibrutinib in Steroid Dependent/Refractory cGVHD Participants

Recruiting
  • Chronic Graft vs Host Disease
    • Bucheon-Si, Korea, Republic of
    • +9 more
    Jan 27, 2023

    Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

    Recruiting
    • Chronic Graft vs Host Disease
    • Regulatory T-cell enriched infusion
    • Sevilla, Spain
      José Antonio Pérez Simón
    May 20, 2022

    Chronic GVHD Trial in Boston (Abatacept)

    Active, not recruiting
    • Chronic Graft Versus Host Disease
    • Boston, Massachusetts
    • +1 more
    Jan 25, 2022

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    Chronic Graft-versus-host-disease Trial in United States (Itacitinib)

    Recruiting
    • Chronic Graft-versus-host-disease
    • Denver, Colorado
    • +4 more
    Jan 24, 2022

    GVHD Trial in Japan (Ibrutinib)

    Completed
    • Graft vs Host Disease
    • Anjo-shi, Japan
    • +14 more
    Dec 30, 2021

    Chronic Graft-versus-host-disease Trial in Shanghai (Anlotinib)

    Terminated
    • Chronic Graft-versus-host-disease
    • Shanghai, Shanghai, China
      Hematology Department
    Mar 22, 2021

    Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)

    Not yet recruiting
    • Steroid-refractory Acute Graft-versus-host Disease
    • MC0518
    • BAT
    • (no location specified)
    Oct 4, 2023

    Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Steroid Refractory Graft Versus Host Disease
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Chronic GVHD Trial in Israel, Italy (nilotinib)

    Completed
    • Chronic Graft Versus Host Disease
    • Tel Hashomer, Israel
    • +11 more
    Aug 19, 2021

    Patients at Risk for Chronic Graft-Versus-Host Disease

    Not yet recruiting
    • cGVHD
    • Non-Interventional
    • (no location specified)
    Jun 16, 2023

    Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)

    Completed
    • Steroid Refractory GVHD
    • Taoyuan, Taiwan
      Chang Gung Memorial Hospital
    Dec 15, 2022

    Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)

    Approved for marketing
    • Graft-versus-host Disease (GVHD)
    • (no location specified)
    Jan 26, 2023

    Chronic Graft-versus-host Disease Trial in Seoul (Imatinib mesylate, Mycophenolate mofetil)

    Terminated
    • Chronic Graft-versus-host Disease
    • Imatinib mesylate, Mycophenolate mofetil
    • Seoul, Chongno-gu, Korea, Republic of
      Seoul National University Children's Hospital
    Oct 21, 2020

    A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease

    Not yet recruiting
    • Graft-versus-Host Disease
    • ruxolitinib
    • (no location specified)
    Jan 11, 2023

    Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

    Completed
    • Myelodysplastic/Myeloproliferative Neoplasm
    • +2 more
    • Decidual stromal cells (DSC)
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Hematological Malignancies Trial in Durham (fostamatinib)

    Active, not recruiting
    • Hematological Malignancies
    • Durham, North Carolina
      Duke University of Medicine
    Jul 14, 2022

    Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • Atlanta, Georgia
      Northside Hospital
    Sep 21, 2023

    Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Duarte, California
      City of Hope Site Number : 8400001
    Nov 23, 2023

    Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

    Active, not recruiting
    • Chronic Graft vs Host Disease
    • Chronic Graft-Versus-Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 29, 2022

    Acute GVHD Trial (MTX, Corticosteroid)

    Not yet recruiting
    • Acute Graft Versus Host Disease
    • (no location specified)
    Jun 26, 2023

    GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

    Terminated
    Has Results
    • Graft Versus Host Disease
    • +2 more
    • Ruxolitinib 1.5% cream
    • vehicle cream
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 21, 2022

    Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

    Completed
    • Steroid-refractory Acute Graft-versus-Host Disease
    • Treatment-refractory Acute Graft-versus-Host Disease
    • Neihulizumab (ALTB-168)
    • Duarte, California
    • +12 more
    Jan 17, 2023

    GVHD Trial in United States (Belumosudil (KD025))

    Completed
    • Graft vs Host Disease
    • Belumosudil (KD025)
    • Duarte, California
    • +6 more
    May 27, 2022